ESTHER
CHAMORRO DE VEGA
Profesora asociada de Ciencias de la Salud
María
Sanjurjo Sáez
Publications by the researcher in collaboration with María Sanjurjo Sáez (8)
2023
-
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study
Pharmacological Reports, Vol. 75, Núm. 5, pp. 1254-1264
2022
-
Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid
Annals of Pharmacotherapy, Vol. 56, Núm. 4, pp. 401-411
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
2020
-
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients
Annals of Pharmacotherapy, Vol. 54, Núm. 7, pp. 633-643
-
Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury
American journal of therapeutics, Vol. 27, Núm. 6, pp. e670-e671
2018
-
Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients
Annals of Pharmacotherapy, Vol. 52, Núm. 1, pp. 11-18
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Switching to a rilpivirine/emtricitabine/tenofovir single-tablet regimen in RNA-suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks
International Journal of Clinical Practice, Vol. 71, Núm. 8